The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-α activity and low tumor necrosis factor α levels in patients with lupus

Arthritis and Rheumatism

Volumn 58, Issue 9, 2008, Pages 2818-2823

  Kariuki, Silvia N ^a   Crow, Mary K ^b   Niewold, Timothy B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PTPN22 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51849117301     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23728     Document Type: Article

References (15)

1. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFNα in systemic lupus erythematosus. Science 2001;294:1540-3.
2. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979;301:5-8.
3. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-α therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005;24:178-81.
4. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFNα activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007;8:492-502.
5. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta-analysis. Rheumatology (Oxford) 2007;46:49-56.
6. Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005;52:2396-402.
7. Mavragani CP, Danielides S, Niewold TB, Kirou KA, Moutsopoulos HM, Crow MK. Activation of the type I interferon pathway in autoimmune thyroid disease. Arthritis Rheum 2007;56 Suppl 9:S229.
8. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 2000;43:1431-42.
9. Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFNα in autoimmune diseases. Proc Natl Acad Sci U S A 2005;102:3372-7.
10. Devendra D, Eisenbarth GS. Interferon α: a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol 2004;111:225-33.
11. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179:4704-10.
12. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK. Augmented interferon-α pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 2007;56:3995-4004.
13. Chapman SJ, Khor CC, Vannberg FO, Maskell NA, Davies CW, Hedley EL, et al. PTPN22 and invasive bacterial disease. Nat Genet 2006;38:499-500.
14. Pierer M, Kaltenhauser S, Arnold S, Wahle M, Baerwald C, Hantzschel H, et al. Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients. Arthritis Res Ther 2006;8:R75.
15. Niewold TB, Adler JE, Glenn SB, Lehman TJ, Harley JB, Crow MK. Age-and sex-related patterns of serum interferon-α activity in lupus families. Arthritis Rheum 2008. In press.